Companies: 10,795·Total market cap: $144.5T
Bio-Techne Corporation

Bio-Techne Corporation

TECHNASDAQHealthcare● Active
$51.99
$-1.19(-2.24%)
Market Cap$8.1B
P/E Ratio
52W High$72.16
52W Low$43.2

Bio-Techne Corporation (TECH) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

tech · stock forecast · 25 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 25 Wall Street analysts in the past 3 months

SellBuy

Buy

25 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
18
Hold
7
Sell
0
Strong Sell
0
Total: 25 · Buy rate: 72.0%

12-Month Price Target

High

$79.00

Consensus

$60.33

+16.0% upside

Low

$49.00

Median: $56 · Last Close: $51.99

The Bio-Techne Corporation (TECH) analyst consensus is Buy, based on ratings from 25 Wall Street analysts over the past 3 months. The average 12-month TECH price target is $60.33, representing +16.0% upside from the current price of $51.99.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $60 (16.0%)

Consensus Target

$60.33

16.0% upside

High Target

$79

52.0%

Low Target

$49

-5.8%

Current Price

$51.99

as of today

Based on analyst price targets, the TECH stock price prediction for the next 12 months ranges from $49 to $79. The consensus TECH price forecast of $60.33 implies 16.0% upside from the current price of $51.99.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$54.194.23%

1-day model range: $53.75–$54.62. Peak: $54.62 (+4.23%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$44-16.2%
2028$39-24.3%
2029$37-28.7%
2030$36-31.2%
2031-32.7%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

NEUTRAL

Based on 14 technical indicators

50%0%50%
7Buy
0Neutral
7Sell
RSI (14)78.3Overbought
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · TECH · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$51.32BUY
MA 10$50.34BUY
MA 20$48.17BUY
MA 50$52.18SELL
MA 100$56.13SELL
MA 200$57.51SELL
Current $TECH · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$51.48BUY
EMA 10$50.51BUY
EMA 20$50.09BUY
EMA 50$51.75BUY
EMA 100$54.15SELL
EMA 200$56.36SELL
Current $TECH · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Wells Fargo2026-05-07
Maintains
OverweightOverweight
Evercore ISI Group2026-05-07
Maintains
In LineIn Line
Citigroup2026-05-07
Maintains
BuyBuy
Evercore ISI Group2026-04-06
Maintains
In LineIn Line
Wells Fargo2026-02-06
Maintains
OverweightOverweight
Evercore ISI Group2026-02-05
Maintains
In LineIn Line
Citigroup2026-02-05
Maintains
BuyBuy
Stifel2026-02-05
Maintains
HoldHold
TD Cowen2026-02-05
Maintains
BuyBuy
UBS2026-02-05
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Bio-Techne Corporation (TECH) stock. Of the recent 125 rating actions, 14 were upgrades and 12 were downgrades. 25 analysts currently cover TECH.

Analyst Recommendation Trends

Buy ratings22
Hold ratings01↑ +1
Sell ratings00

TECH analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 2 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$1.2B

↓ 12.5% YoY

Revenue Next Year

$1.3B

↑ 4.6% YoY

EPS This Year

$1.93

EPS Next Year

$2.07

↑ 7.3% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast TECH EPS of $1.93 for the current fiscal year, based on estimates from 8 analysts. The TECH revenue forecast is $1.2B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The TECH stock forecast is supported by two independent data sources: analyst consensus ratings from 25 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus TECH price target is $60.33 (+16.0% upside), with an analyst consensus of Buy.

The TECH short-term stock prediction for tomorrow is $54.19 (+4.23%). The TECH stock price prediction for 2027 estimates an average of $44. The TECH stock prediction for 2030 projects a range of $33–$39.

Bio-Techne Corporation trades on NASDAQ under the ticker TECH. The TECH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 72% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

TECH forecast · 8 questions

According to 25 Wall Street analysts, the average 12-month TECH price target is $60.33, with a high forecast of $79.00 and a low of $49.00. The median price target is shown in the chart above when available. This implies +16.0% potential upside from the current price of $51.99.

TECH price targetWhat is TECH price targetTECH analyst price targetTECH 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.